Denali Therapeutics Stock Quote DNLI - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

13.89

Bid

12.00

Ask

25.00

Volume

1,528,651

13.57 Day's Range 14.13

10.57 52 Week Range 33.33

Market Cap

2.018B

Previous Close

14.09

Open

14.13

Last Trade

14.05

Last Trade Time

Financial Volume

$ 21,406,894

VWAP

14.0038

Average Volume (3m)

1,588,922

Shares Outstanding

145,276,299

Dividend Yield

PE Ratio

-4.77

Earnings Per Share (EPS)

-2.91

Revenue

Net Profit

-422.77M

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.denalitherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

Denali Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker DNLI. The last closing price for Denali Therapeutics was $14.09. Over the last year, Denali Therapeutics shares have traded in a share price range of $ 10.57 to $ 33.33.

Denali Therapeutics currently has 145,276,299 shares outstanding. The market capitalization of Denali Therapeutics is $2.05 billion. Denali Therapeutics has a price to earnings ratio (PE ratio) of -4.77.

Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome

SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.68	-4.66712422787	14.57	14.96	13.68	1314237	14.3692992	CS
4	0.56	4.20105026257	13.33	15.69	12.86	1639143	14.18955908	CS
12	-0.25	-1.76803394625	14.14	16.97	10.57	1588922	13.97803428	CS
26	-7.48	-35.0023397286	21.37	24.345	10.57	1301844	16.1300143	CS
52	-6.57	-32.1114369501	20.46	33.33	10.57	1123953	20.06424709	CS
156	-10.63	-43.352365416	24.52	39.43	10.57	939619	22.58163096	CS
260	-9.76	-41.2684989429	23.65	93.94	10.57	801138	30.41121299	CS

DNLI - Frequently Asked Questions (FAQ)

What is the current Denali Therapeutics share price?

The current share price of Denali Therapeutics is $ 13.89

How many Denali Therapeutics shares are in issue?

Denali Therapeutics has 145,276,299 shares in issue

What is the market cap of Denali Therapeutics?

The market capitalisation of Denali Therapeutics is USD 2.05B

What is the 1 year trading range for Denali Therapeutics share price?

Denali Therapeutics has traded in the range of $ 10.57 to $ 33.33 during the past year

What is the PE ratio of Denali Therapeutics?

The price to earnings ratio of Denali Therapeutics is -4.77

What is the reporting currency for Denali Therapeutics?

Denali Therapeutics reports financial results in USD

What is the latest annual profit for Denali Therapeutics?

The latest annual profit of Denali Therapeutics is USD -422.77M

What is the registered address of Denali Therapeutics?

The registered address for Denali Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Denali Therapeutics website address?

The website address for Denali Therapeutics is www.denalitherapeutics.com

Which industry sector does Denali Therapeutics operate in?

Denali Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NXTTNext Technology Holding Inc	$ 3.44 (158.65%)	13.84M
WHLRWheeler Real Estate Investment Trust Inc	$ 7.15 (109.06%)	52.35M
CTORCitius Oncology Inc	$ 2.63 (69.68%)	20.77M
LUCYInnovative Eyewear Inc	$ 3.52 (54.39%)	111.21M
LGCLLucas GC Ltd	$ 1.0407 (53.16%)	11.17M
NWGLNature Wood Group Ltd	$ 1.71 (-69.63%)	3.99M
ICUSeaStar Medical Holding Corporation	$ 0.351 (-64.05%)	21.9M
MBRXMoleculin Biotech Inc	$ 0.259999 (-55.40%)	16.84M
RGCRegencell Bioscience Holdings Ltd	$ 37.50 (-40.81%)	2.22M
CGTLCreative Global Technology Holdings Ltd	$ 1.4399 (-36.57%)	6.71M
HCTIHealthcare Triangle Inc	$ 0.0297 (12.08%)	583.72M
DFLIDragonfly Energy Holdings Corporation	$ 0.245 (12.39%)	334.37M
GNLNGreenlane Holdings Inc	$ 0.009 (-13.04%)	262.88M
NVDANVIDIA Corporation	$ 143.85 (-1.12%)	242.95M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.359 (-0.09%)	193.97M